Clinical Trial Update: LYR-220 for Adult Subjects With Chronic Rhinosinusitis (BEACON Study) [Phase 2]

View source ↗

Summary

Lyra Therapeutics’ Phase 2 BEACON trial of LYR-220 in adults with chronic rhinosinusitis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis

Drugs mentioned

• LYR-220

Snippet

Sponsor: Lyra Therapeutics | Conditions: Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis) | Phase 2 | Status: COMPLETED | Results posted: 2024-12-17